PMDA drug package insert
イスクラ冠元顆粒
PMDA OTC drug · イスクラ産業株式会社 · package insert Jun 1, 2026
Key facts
| Brand names | イスクラ冠元顆粒 |
|---|---|
| Companies | 製造販売元／イスクラ産業株式会社 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 生薬製剤（他の薬効群に属さない製剤） |
| Package insert date | Jun 1, 2026 |
| PMDA document key | 130091_J1101000167 |
| PMDA company code | 130091 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: